Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine
Donald Lavelle(University of Illinois Chicago), Yogen Saunthararajah(Cleveland Clinic)
Cited by 100
Related Papers
Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates
|Journal of Clinical Investigation|2018|117
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition
|Journal of Clinical Investigation|2017|49
Noncytotoxic Differentiation Treatment of Renal Cell Cancer
|Cancer Research|2011|33
S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis)
|Journal of Translational Medicine|2010|30